Fenebrutinib in Relapsing MS: FENhance Trial Results Explained

Fenebrutinib in Relapsing MS: FENhance Trial Results Explained

New Phase 3 data presented at the AAN conference 2026 provide compelling evidence that fenebrutinib may represent a high-efficacy oral treatment option for people living with relapsing multiple sclerosis.

In this exclusive episode, leading experts Prof. Ludwig Kappos from University of Basel and Dr. Jiwon Oh from Barlo MS Centre join host Brett Drummond to unpack the full FENhance 1 & 2 trial results.

Together, they explore:

  • How fenebrutinib performed against teriflunomide in relapsing MS
  • Why BTK inhibition continues to generate strong interest across the MS treatment landscape
  • What the results reveal about relapse reduction, MRI outcomes, and disability progression
  • What the safety profile of fenebrutinib looked like in this cohort of patients

Listen for a deep dive into the science, clinical context, and future implications for MS care.

-----------------------------

This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(81)

How Technology Is Transforming Multiple Sclerosis Care

How Technology Is Transforming Multiple Sclerosis Care

Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of John...

12 Elo 31min

Should High-Risk Populations Be Screened for Multiple Sclerosis?

Should High-Risk Populations Be Screened for Multiple Sclerosis?

Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration ...

30 Heinä 32min

How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

Where someone lives can profoundly influence their multiple sclerosis journey. While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still f...

16 Heinä 27min

MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis

MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis

Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research. In each episode, leading MS experts will take a sm...

2 Heinä 23min

Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation

Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation

Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice? In this episode of the ECTRIMS Podcast, host Brett Drummond...

18 Kesä 31min

Can the revised 2024 McDonald Diagnostic criteria solve the misdiagnosis problem in multiple sclerosis?

Can the revised 2024 McDonald Diagnostic criteria solve the misdiagnosis problem in multiple sclerosis?

In this episode of the ECTRIMS Podcast, recorded in collaboration with the Multiple Sclerosis Journal "Controversies in MS" series, host Prof. Anneke van der Walt moderates a discussion between Prof. ...

3 Kesä 33min

EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?

EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?

Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the ...

15 Touko 29min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
docemilia
rss-hereilla
rss-bios-podcast
utelias-mieli
hippokrateen-vastaanotolla
rss-metsanomistaja-podcast
rss-lapsuuden-rakentajat-podcast
rss-sosiopodi
filocast-filosofian-perusteet
rss-tiedetta-vai-tarinaa
rss-duodecim-lehti
radio-antro
rss-totuuden-liepeilla